DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS. Herek TA, Bouska A, Lone W, Sharma S, et al. Blood 2022;140:1278-1290.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Herek TA, Bouska A, Lone W, Sharma S, et al. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS. Blood 2022;140:1278-1290.
PMID: 35639959